These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1093299)

  • 1. Immunotherapy with cultured human cells and BCG.
    Sokal JE; Aungst CW
    Transplant Proc; 1975 Jun; 7(2):317-21. PubMed ID: 1093299
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunotherapy of chronic myelocytic leukemia.
    Sokal JE; Aungst CW; Grace JT
    Natl Cancer Inst Monogr; 1973 Dec; 39():195-8. PubMed ID: 4595316
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of Bacillus Calmette-Guérin as adjuvant in human cell vaccines.
    Sokal JE; Aungst CW; Han T
    Cancer Res; 1972 Jul; 32(7):1584-9. PubMed ID: 4624098
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunologic studies in lymphoma and leukemia, and exploration of antitumor immunotherapy.
    Sokal JE
    J Surg Oncol; 1973 Jun; 5(6):557-66. PubMed ID: 4589652
    [No Abstract]   [Full Text] [Related]  

  • 5. The occurrence of antibodies against single-stranded DNA in the sera of patients with acute and chronic leukaemia.
    Izui S; Lambert PH; Carpentier N; Miescher PA
    Clin Exp Immunol; 1976 Jun; 24(3):379-84. PubMed ID: 780020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing patients' sarcoma-specific immune responses during immunotherapy.
    Williams DE; Romero JJ; Sinkovics JG; Campos LT
    Tex Med; 1975 Jun; 71(6):55-60. PubMed ID: 1056644
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunotherapy with BCG and leukemic blast cells during complete remission of acute myeloid leukemia.
    Gobbi M; Ruggero D; Baccarani M; Zaccaria A; Tomasini I; Tura S
    Haematologica; 1977 Oct; 62(5):529-36. PubMed ID: 412739
    [No Abstract]   [Full Text] [Related]  

  • 8. Progress report on immunotherapy of chronic myeloid leukemia.
    Sokal JE; Carpenter N; Nizet C
    Boll Ist Sieroter Milan; 1978 Jul; 57(3):294-305. PubMed ID: 282900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active specific immunotherapy for acute myelogenous leukaemia.
    Powles R
    Johns Hopkins Med J Suppl; 1974; 3():333-40. PubMed ID: 4609353
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative and combined effect of BCG and neuraminidase in experimental immunotherapy.
    Simmons RL; Rios A
    Natl Cancer Inst Monogr; 1973 Dec; 39():57-68. PubMed ID: 4595327
    [No Abstract]   [Full Text] [Related]  

  • 11. BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease.
    Mathé G; Weiner R; Pouillart P; Schwarzenberg L; Jasmin C; Schneider M; Hayat M; Amiel JL; de Vassal F; Rosenfeld C
    Natl Cancer Inst Monogr; 1973 Dec; 39():165-75. PubMed ID: 4595314
    [No Abstract]   [Full Text] [Related]  

  • 12. BCG-RIVM: a new BCG preparation for intravesical immunotherapy of superficial bladder cancer.
    Schreinemachers L; Van der Meyden A; Steerenberg P; Feitz W; Groothuis D; De Jong W; Debruyne F
    Chemioterapia; 1987 Jun; 6(2 Suppl):713-6. PubMed ID: 3334665
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunotherapy of acute myelogenous leukemia in man.
    Powles R
    Natl Cancer Inst Monogr; 1973 Dec; 39():243-7. PubMed ID: 4595324
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of BCG on in vitro immune reactivity and clinical course in dogs treated surgically for osteosarcoma.
    Bech-Nielsen S; Brodey RS; Fidler IJ; Abt DA; Reif JS
    Eur J Cancer (1965); 1977 Jan; 13(1):33-41. PubMed ID: 321227
    [No Abstract]   [Full Text] [Related]  

  • 15. BCG in cancer immunotherapy: results obtained with various BCG preparations in a screening study for systemic adjuvants applicable to cancer immunoprophylaxis or immunotherapy.
    Mathé G; Halle-Pannenko O; Bourut C
    Natl Cancer Inst Monogr; 1973 Dec; 39():107-13. PubMed ID: 4150738
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial: BCG in cancer.
    Br Med J; 1976 Jun; 1(6024):1487. PubMed ID: 776334
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyperthermia increases the susceptibility of chondro- and osteosarcoma cells to natural killer cell-mediated lysis.
    Kubista B; Trieb K; Blahovec H; Kotz R; Micksche M
    Anticancer Res; 2002; 22(2A):789-92. PubMed ID: 12014651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy by BCG against prostate adenocarcinomas in anatomical compartments.
    Pollard M; Luckert PH
    Anticancer Res; 1994; 14(6B):2691-4. PubMed ID: 7872703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of growth and dissemination of Shay myelogenous leukemic tumor in rats by glucan and glucan activated macrophages.
    Di Luzio NR; Mcnamee R; Jones E; Lassoff S; Sear W; Hoffmann EO
    Adv Exp Med Biol; 1976; 73 Pt B():397-413. PubMed ID: 793341
    [No Abstract]   [Full Text] [Related]  

  • 20. BCG in the therapy of cancer.
    Delmonte L; Oettgen HF
    Clin Bull; 1975; 5(2):69-71. PubMed ID: 776445
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.